#21 Most Valued WorldwideNVO ā€¢ NYSEHealthcareRead on GrokipediaWWikipediaLive Market Capitalization
Novo Nordisk A/S
Headquartered in BagsvƦrd, Denmark ā€¢ Led by CEO Lars Fruergaard JĆørgensen
Enterprise Market Capitalization
$405.0 Billion
-0.69% ($2.8B 24h)
Share Price: $118.00 USD
Share Price
$118.00
NVO
P/E Ratio
38.6x
Price to Earnings
Annual Revenue
$33.7B
TTM Revenue
Founded
1923
103 Years Active
Employees
64,300
Global Workforce
Exchange
NYSE
Denmark
Corporate Overview
Novo Nordisk is a leading global healthcare company with a centurylong heritage in diabetes care, recently becoming Europe's most valuable company on the meteoric success of its weight-loss therapies Ozempic and Wegovy.
Core Business Divisions & Flagship Offerings
Ozempic (Semaglutide)
Wegovy
Rybelsus
NovoLog / NovoRapid Insulin
Explore All 100 Most Valued Companies
Compare market caps, sector distribution, and major shareholder networks.